Lung Pseudomesothelioma in Patient with Asbestos Exposure: A Case Report
Downloads
Background: Pseudomesotheliomatous carcinoma is a rare case of lung cancer with marked pleural extension resembling malignant pleural mesothelioma on diagnostic imaging. One of tool to diagnose lung pseudomesothelioma is by performing thorocoscopy pleural biopsy. Diagnostic thoracoscopy also has a higher sensitivity than pleural fluid cytology and needle biopsy.
Case: We report a rare case of pseudomesotheliomatous carcinoma of the lung in a 50-year-old man with asbestos exposure. The patient had complained of dyspnea and chest roentgenogram showed left pleural effusion. Computed tomography (CT) of the chest revealed diffuse irregular left pleural thickening and without a clear initial primary lesion found in both of lung parenchyma, which mimicked pleural mesothelioma. Pleural tissue sampling was performed to obtain definitive diagnosis by video-assisted thoracoscopic surgery. At the operation, the tumor was found to have spread along the pleural surface and primary lesion was not detected in the right lung parenchyma. Immunohistochemically, the tumor was positive for Thyroid Transcription Factor- 1 (TTF-1), but negative for calretinin, P63, and Neuron Specific Enolase (NSE). Final diagnosis was adenocarcinoma of the lung and patient had good clinical response to Gefitinib.
Conclusion: Based on the results of clinical studies (images and clinical observations), although pseudomesotheliomatous in patient with asbestos exposure is difficult to distinguish from pleural mesothelioma, we have a case of pseudomesotheliomatous lung diagnosed by a thoracoscopic pleura biopsy. For such cases, thoracoscopic pleural biopsy should be performed at an early stage.
Maeda R, Isowa N, Kawasaki Y, et al. [Pseudomesotheliomatous Carcinoma of the Lung]. Kyobu Geka the Japanese Journal of Thoracic Surgery. 2007; 60: 555-558.
Dodson RF and Hammar SP. Analysis of Asbestos Concentration in 20 Cases of Pseudomesotheliomatous Lung Cancer. Ultrastructural Pathology. 2015; 39: 13-22.
Harwood TR, Gracey DR and Yokoo H. Pseudomesotheliomatous Carcinoma of the Lung. A Variant of Peripheral Lung Cancer. American Journal of Clinical Pathology. 1976; 65: 159-167.
Dunitz M. In: Robinson BWS and Chahinian AP, (Eds.). Mesothelioma. London: Martin Dunitz Ltd., Taylor & Francis Group. 2005; 1-93.
Goswami E, Craven V, Dahlstrom DL, Alexander D and Mowat F. Domestic Asbestos Exposure: A Review of Epidemiologic and Exposure Data. Int J Environ Res Public Health. 2013; 10: 5629-5670.
Dasar-Dasar Diagnosis Kanker Paru. Jakarta: Universitas Indonesia Press, 2017.
Moran C, Suster S. Tumors and Tumor-Like Conditions of the Lung and Pleura. 2010; 1-465.
Network NCC. Malignant Pleural Mesothelioma. In: Oncology NCPGI, (Ed.). Pennsylvania: National Comprehensive Cancer Network, 2017.
Astoul P, Boutin C. Pleuroscopy in the Management of
Malignant Pleural Mesothelioma. In: Robinson BWS and Chahinian AP, (Eds.). Mesothelioma. London: Martin Dunitz Ltd., Taylor & Francis Group, 2005; 127-142.
Simonsen J. Pseudomesotheliomatous Carcinoma of the Lung with Asbestos Exposure. The American Journal of Forensic Medicine and Pathology. 1986; 7: 49-51.
Attanoos RL and Gibbs AR. ‘Pseudomesotheliomatous' Carcinomas of the Pleura: A 10-Year Analysis of Cases from the Environmental Lung Disease Research Group, Cardiff. Histopathology. 2003; 43: 444-452.
Hood J. Peran Imunohistokimia pada Diagnosis Patologi. Surabaya: Fakultas Kedokteran Universitas Airlangga, 1993; 1-11.
British Thoracic Society Standards of Care Committee. Statement on Malignant Mesothelioma in the United Kingdom. Thorax. 2001; 56: 250-65.
Ordonez NG. The Immunohistochemical Diagnosis of Mesothelioma: A Comparative Study of Epithelioid Mesothelioma and Lung Adenocarcinoma. The American Journal of Surgical Pathology. 2003; 27: 1031-51.
Segal A, Combrinck M, Chai SM. Pleural Fluid Cytology. In: Light RW and Lee YCG, (Eds.). Textbook of Pleural Diseases. 3rd Ed. Florida: CRC Press, 2017; 251-65.
Segal A, Whitaker D, Henderson D and Shilkin K. Pathology of Mesothelioma. In: Robinson BWS and Chahinian AP, (Eds.). Mesothelioma. London: Martin Dunitz Ltd., Taylor & Francis Group, 2005; 143-176.
Copyright (c) 2020 Devy Trianne Putri, Isnin Anang Marhana, Dhihintia Jiwangga
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).
4. The Creative Commons Attribution Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violation.